DUSTIN DENICOLA: Open Payments
NPI 1831758143 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60 in 3 payments from 3 companies in 2025. Trend: 2023 $86 · 2024 $154 · 2025 $60
Food & beverage: $60
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Kite Pharma, Inc. | 1 | $17 |
Products named: CABLIVI, ZENPEP, Yescarta.
Industry payments across LA — which companies pay providers there.
